Free Trial

Growth Stocks To Research - March 13th

Novo Nordisk A/S logo with Medical background
Remove Ads

Novo Nordisk A/S, Blackstone, and BlackRock are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares in companies that are expected to grow their revenues and earnings at a faster pace than the broader market. These companies typically reinvest profits into further expansion rather than paying dividends, appealing to investors seeking high potential returns despite higher volatility. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

NYSE:NVO traded up $1.13 during trading hours on Thursday, hitting $75.92. 4,556,186 shares of the company were exchanged, compared to its average volume of 5,371,893. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.74 and a quick ratio of 0.55. Novo Nordisk A/S has a 52-week low of $73.80 and a 52-week high of $148.15. The stock has a market capitalization of $340.70 billion, a price-to-earnings ratio of 23.15, a PEG ratio of 0.90 and a beta of 0.42. The company's 50 day moving average price is $84.39 and its 200-day moving average price is $103.83.

Read Our Latest Research Report on NVO

Blackstone (BX)

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.

Remove Ads

Shares of NYSE BX traded down $3.93 during mid-day trading on Thursday, hitting $136.61. The stock had a trading volume of 1,927,653 shares, compared to its average volume of 3,322,515. The company has a 50 day moving average of $167.34 and a two-hundred day moving average of $167.06. Blackstone has a twelve month low of $115.82 and a twelve month high of $200.96. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.71 and a current ratio of 0.67. The firm has a market cap of $99.64 billion, a PE ratio of 37.62, a PEG ratio of 1.07 and a beta of 1.55.

Read Our Latest Research Report on BX

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Shares of BLK stock traded down $7.18 during mid-day trading on Thursday, reaching $902.88. The stock had a trading volume of 280,964 shares, compared to its average volume of 838,707. The company has a current ratio of 5.23, a quick ratio of 5.23 and a debt-to-equity ratio of 0.45. BlackRock has a 1-year low of $745.55 and a 1-year high of $1,084.22. The firm has a market cap of $140.18 billion, a price-to-earnings ratio of 21.50, a PEG ratio of 1.90 and a beta of 1.29. The business's fifty day moving average is $987.79 and its 200-day moving average is $985.88.

Read Our Latest Research Report on BLK

See Also

Should You Invest $1,000 in Novo Nordisk A/S Right Now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads